Armed oncolytic adenovirus can overcome critical obstacles in adoptive T-cell therapy of solid tumors

被引：0
|
作者：
Hemminki, Akseli [1 ,2 ,3 ]
Siurala, Mikko [1 ,2 ,3 ]
Tahtinen, Siri
Jokimaki, Riikka
Bramante, Simona
Parviainen, Suvi
机构：
[1] Univ Helsinki, Haartman Inst, Dept Pathol, Canc Gene Therapy Grp, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Transplantat Lab, FIN-00014 Helsinki, Finland
[3] TILT Biotherapeut Ltd, Helsinki, Finland
来源：
HUMAN GENE THERAPY | 2014年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
INV085
引用
收藏
页码：A20 / A20
页数：1
相关论文
共 50 条
  • [1] Oncolytic adenoviruses armed with TNFα and IL-2 enable successful adoptive T-cell therapy of solid tumors
    Parviainen, S.
    Havunen, R.
    Siurala, M.
    Tahtinen, S.
    Saha, D.
    Vaha-Koskela, M.
    Behr, M.
    Nettelbeck, D.
    Ehrhardt, A.
    Hemminki, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 1 - 1
  • [2] Treating pancreatic cancer with "armed" oncolytic adenoviruses and adoptive T-cell therapy
    Roach, Brett L.
    Yamamoto, Masato
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Combating Solid Tumors with Adoptive T-Cell Therapy
    Genetic Engineering and Biotechnology News, 2022, 42 (07): : 28 - 29
  • [4] Syrian hamster model for adoptive T-cell transfer and oncolytic adenovirus combination therapy
    Siurala, M.
    Vaha-Koskela, M.
    Tahtinen, S.
    Parviainen, S.
    Hemminki, A.
    HUMAN GENE THERAPY, 2015, 26 (10) : A33 - A33
  • [5] Is adoptive T-cell therapy for solid tumors coming of age?
    Pedrazzoli, P.
    Comoli, P.
    Montagna, D.
    Demirer, T.
    Bregni, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 (08) : 1013 - 1019
  • [6] Is adoptive T-cell therapy for solid tumors coming of age?
    P Pedrazzoli
    P Comoli
    D Montagna
    T Demirer
    M Bregni
    Bone Marrow Transplantation, 2012, 47 : 1013 - 1019
  • [7] Enabling successful T-cell therapy of solid tumors with oncolytic adenoviruses armed with TNFα and IL-2
    Hemminki, A.
    Havunen, R.
    Siurala, M.
    Taehtinen, S.
    Saha, D.
    Vaehae-Koskela, M.
    Behr, M.
    Nettelbeck, D.
    Ehrhardt, A.
    Parviainen, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable successful adoptive T cell therapy of solid tumors
    Siurala, Mikko
    Havunen, Riikka
    Santos, Joao
    Tahtinen, Siri
    Saha, Dipongkor
    Vaha-Koskela, Markus
    Behr, Michael
    Nettelbeck, Dirk M.
    Ehrhardt, Anja
    Parviainen, Suvi
    Hemminki, Akseli
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [9] CAR T cell therapy in solid tumors; with an extensive focus on obstacles and strategies to overcome the challenges
    Khorasani, Ayda Baghery Saghchy
    Sanaei, Mohammad-Javad
    Pourbagheri-Sigaroodi, Atieh
    Ghaffari, Seyed H.
    Bashash, Davood
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [10] Magnetic Nanoclusters Armed with Responsive PD-1 Antibody Synergistically Improved Adoptive T-Cell Therapy for Solid Tumors
    Nie, Weidong
    Wei, Wei
    Zuo, Liping
    Lv, Chengliang
    Zhang, Fan
    Lu, Gui-Hong
    Li, Feng
    Wu, Guanghao
    Huang, Li-Li
    Xi, Xiaobo
    Xie, Hai-Yan
    ACS NANO, 2019, 13 (02) : 1469 - 1478
12345